Primary vitreoretinal lymphoma
Showing 1 - 25 of >10,000
Primary Vitreoretinal Lymphoma Trial in Beijing (Intravitreal injection of methotrexate)
Recruiting
- Primary Vitreoretinal Lymphoma
- Intravitreal injection of methotrexate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 11, 2023
Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma Trial (intensity-modulated radiotherapy (IMRT))
Not yet recruiting
- Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
- intensity-modulated radiotherapy (IMRT)
- (no location specified)
Jun 4, 2023
Primary Vitreoretinal Lymphoma Trial in Beijing (Methotrexate, Rituximab, Zanubrutinib)
Recruiting
- Primary Vitreoretinal Lymphoma
- Methotrexate
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 19, 2021
Molecular Diagnostic for VitreoRetinal Lymphoma
Not yet recruiting
- Vitreoretinal Lymphoma
- (no location specified)
Apr 21, 2023
Primary Intraocular Lymphoma Trial in Beijing (Methotrexate, Rituximab, Lenalidomide)
Recruiting
- Primary Intraocular Lymphoma
- Methotrexate
- +2 more
-
Beijing, Beijing, ChinaPeking Union medical college hospital
Oct 7, 2019
Lymphoma, Primary Effusion Trial run by the National Cancer Institute (NCI) (Daratumumab SC)
Not yet recruiting
- Lymphoma, Primary Effusion
- Daratumumab SC
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 23, 2023
CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma
Active, not recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- DISEASE
- (no location specified)
May 4, 2023
Primary Ocular Adnexal MALT Lymphoma Trial (Rituximab, Involved Site Radiation Therapy)
Not yet recruiting
- Primary Ocular Adnexal MALT Lymphoma
- Rituximab
- Involved Site Radiation Therapy
- (no location specified)
Sep 26, 2023
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
Recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
-
Milan, ItalyOspedale San Raffaele
Aug 29, 2023
Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell
Not yet recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- +5 more
- Pembrolizumab
- +3 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2023
Relapsed or Refractory (R/R) Primary CNS Lymphoma Trial in Nanjing (thiotepa combined with pomalidomide)
Recruiting
- Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma
- thiotepa combined with pomalidomide
-
Nanjing, Jiangsu, ChinaJiangsu Province People's Hospital.
Jun 27, 2023
Mutation Detection for VRL
Enrolling by invitation
- Vitreoretinal Lymphoma
- Uveitis
- mutation test
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Nov 12, 2021
Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Cyclophosphamide)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Rituximab
- +4 more
- (no location specified)
Mar 9, 2023
Primary CNS Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Methotrexate)
Completed
- Primary Central Nervous System Lymphoma
- Rituximab
- +2 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 18, 2022
Primary CNS Lymphoma Trial in Hanzhou (Orelabrutinib, Rituximab, Methotrexate)
Recruiting
- Primary Central Nervous System Lymphoma
- Orelabrutinib
- +2 more
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 3, 2022
Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)
Not yet recruiting
- Diffuse Large B Cell Lymphoma (DLBCL)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Sep 18, 2023
Refractory CNS Lymphoma, Relapsed Primary CNS Lymphoma, Primary CNS Lymphoma Trial in Hangzhou (Nivolumab)
Active, not recruiting
- Refractory Central Nervous System Lymphoma
- +2 more
-
Hangzhou, Zhejiang, ChinaJianmin Zhang
Jul 3, 2022
Primary CNS Lymphoma Trial in Beijing (Orelabrutinib,Rituximab and Methotrexate)
Recruiting
- Primary Central Nervous System Lymphoma
- Orelabrutinib,Rituximab and Methotrexate
-
Beijing, Beijing, ChinaHospital 307
Sep 19, 2022
Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- +3 more
- Pemetrexed
- +3 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022
Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))
Recruiting
- Primary Central Nervous System Lymphoma
- Glucarpidase
- Methotrexate (MTX)
-
Paris, FranceHôpital Pitié-Salpêtrière
Oct 24, 2022
Primary CNS Lymphoma Trial in Paris (PET-MRI)
Not yet recruiting
- Primary Central Nervous System Lymphoma
-
Paris, FranceHôpital Pitié Salpêtrière
May 20, 2022
T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail
Recruiting
- T-cell Lymphoma
- +30 more
- Optional Blood Sample
- Optional Nail Sample
-
Duarte, California
- +25 more
Jul 28, 2023